This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The excimer laser photoablation has undergone more than 3 years of clinical testing in sighted eyes.1-3 A summary of the clinical results of excimer laser photoablation presented during the annual meeting of the American Academy of Ophthalmology in Anaheim, Calif, October 8-11, 1991, is listed in Table 1. Although the final figures are yet to be published, the available numbers demonstrate that excimer laser photoablation (photorefractive keratectomy, [PRK]) is a viable technique for the correction of myopia.
See also pp 1230 and 1286.
In a previous editorial,10 I expressed cautious optimism for the future potential of PRK. In that editorial, I compared the technique to the most commonly performed refractive procedure—radial keratotomy (RK).10 In this issue of the Archives, Seiler and coworkers11 compare the clinical results of PRK in 298 sighted eyes with those of the Prospective Evaluation of Radial Keratotomy (PERK) study121
Binder PS. Excimer Laser Photoablation Clinical Results and Treatment of Complications in 1992. Arch Ophthalmol. 1992;110(9):1221–1222. doi:10.1001/archopht.1992.01080210039018
Customize your JAMA Network experience by selecting one or more topics from the list below.